Top 25 Imbruvica Manufacturers for Blood Cancer Treatment
Are you on a quest to find the best Imbruvica manufacturer? You’re not alone! With so many options out there, it can feel overwhelming. The quality of your supplier directly impacts not just your bottom line, but also patient outcomes. Imagine having access to the top factories that ensure high-quality production and reliability. Choosing the right manufacturer can lead to improved efficiency, better pricing, and peace of mind. Ready to navigate this essential decision?
Dive into our article, where we compare the top 30 Imbruvica manufacturers, helping you make an informed choice for your business. Let’s get started!
Top 25 Imbruvica Manufacturer Manufacturers
Imbruvica – Blood Cancer Treatment Solutions
Domain: imbruvica.com
Registered: 2013 ( 12 years )
Introduction: Imbruvica is a prescription medication used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
Drugs.com – Blood Cancer Treatment Solutions
Domain: drugs.com
Registered: 1998 ( 27 years )
Introduction: Imbruvica (ibrutinib) is a medication used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
Jnj – Oncology Therapeutics
Domain: jnj.com
Registered: 1993 ( 32 years )
Introduction: Imbruvica (ibrutinib) oral suspension formulation for adult patients.
Jnj Medical Connect – Blood Cancer Treatment Solutions
Domain: jnjmedicalconnect.com
Registered: 2024 ( 1 years )
Introduction: IMBRUVICA® (ibrutinib) is a medication co-developed and co-commercialized by Janssen Biotech, Inc. and Pharmacyclics LLC, an AbbVie company, primarily used for the treatment of certain types of blood cancers.
Pharmaphorum – CLL Treatment Solutions
Domain: pharmaphorum.com
Registered: 2009 ( 16 years )
Introduction: Imbruvica is a medication used in the treatment of chronic lymphocytic leukemia (CLL).
Imbruvica – B-cell Malignancy Treatment Solutions
Domain: imbruvicahcp.com
Registered: 2015 ( 10 years )
Introduction: IMBRUVICA® is a medication used for the treatment of B-cell malignancies, including chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).
Pharmaceutical Technology – Innovative Pharmaceutical Solutions
Domain: pharmaceutical-technology.com
Registered: 2000 ( 25 years )
Introduction: Imbruvica is a medication developed by AbbVie and Janssen, recently receiving expanded FDA approval.
Innovative Medicine – Targeted Cancer Therapies
Domain: innovativemedicine.jnj.com
Registered: 1993 ( 32 years )
Introduction: IMBRUVICA® (ibrutinib) is a once-daily oral medication approved for the treatment of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), Waldenström’s macroglobulinemia (WM), and chronic graft versus host disease (cGVHD). It is now available in an oral suspension formulation.
Dir – Ibrutinib Capsules for Blood Cancer Treatment
Domain: dir.indiamart.com
Registered: 1996 ( 29 years )
Introduction: The company primarily offers Ibrutinib capsules and tablets in various brands and formulations, primarily for the treatment of blood cancer and mantle cell lymphoma.
On – Pharmaceutical Health Solutions
Domain: on.rxcoverage.ca
Registered: 2021 ( 4 years )
Introduction: The company offers a range of pharmaceutical products, including medications for various health conditions.
Freed Pharma – Pharmaceutical Products and Solutions
Domain: freedpharma.com
Registered: 2022 ( 3 years )
Introduction: Freed Pharma LLP offers a range of pharmaceutical products including tablets, injections, and capsules. Their product line includes multivitamins, antibiotics, pain relievers, and other medicinal formulations.
Fierce Pharma – Cancer Treatment Solutions
Domain: fiercepharma.com
Registered: 2007 ( 18 years )
Introduction: Imbruvica is a cancer treatment drug developed by AbbVie, primarily used for certain types of blood cancers.
Imbruvica – Cancer Treatment Solutions
Domain: imbruvica.jp
Registered: 2013 ( 12 years )
Introduction: イムブルビカ®は、慢性リンパ性白血病(CLL)/小リンパ球性リンパ腫(SLL)、マントル細胞リンパ腫(MCL)、慢性移植片対宿主病(慢性GVHD)、原発性マクログロブリン血症(WM)/リンパ形質細胞リンパ腫(LPL)の治療薬です。
Milliman – Medicare Drug Price Negotiation Solutions
Domain: milliman.com
Registered: 1995 ( 30 years )
Introduction: Medicare Drug Price Negotiation Program (MDPNP) offers negotiated prices for selected Part D drugs, known as maximum fair prices (MFPs), which will take effect on January 1, 2026.
Exportersindia – Ibrutinib Cancer Treatment Capsules
Domain: exportersindia.com
Registered: 1997 ( 28 years )
Introduction: Ibrutinib 140mg Capsules & Tablets, primarily offered under the brand name Nitib, are used for the treatment of various types of cancer, including mantle-cell lymphoma and chronic lymphocytic leukemia.
Indegene – Pharmaceutical Products for Medicare Beneficiaries
Domain: indegene.com
Registered: 1998 ( 27 years )
Introduction: The company offers a range of pharmaceutical products that are subject to price negotiations under the Inflation Reduction Act, focusing on drugs used by Medicare beneficiaries.
Pharmacompass – Oncology Drug Development Solutions
Domain: pharmacompass.com
Registered: 2014 ( 11 years )
Introduction: Ibrutinib is an orally bioavailable, small-molecule inhibitor of Bruton’s tyrosine kinase (BTK) with potential antineoplastic activity.
Ema – Blood Cancer Treatment Solutions
Domain: ema.europa.eu
Registration year: Not available
Introduction: Imbruvica is a medication used for the treatment of certain types of blood cancers.
FDA – Ibrutinib for Pediatric cGVHD Treatment
Domain: fda.gov
Registered: 2000 ( 25 years )
Introduction: Ibrutinib (Imbruvica) is approved for pediatric patients ≥ 1 year of age with chronic graft versus host disease (cGVHD) after failure of 1 or more lines of systemic therapy.
Wemanufacturerdrugcoupons – Imbruvica Savings Programs
Domain: wemanufacturerdrugcoupons.com
Registered: 2022 ( 3 years )
Introduction: Imbruvica is a prescription medication used for the treatment of Chronic Lymphocytic Leukemia and other conditions. The company offers coupons and savings programs to reduce the cost of the medication.
Medlibrary – Hematology Medication Solutions
Domain: medlibrary.org
Registered: 2004 ( 21 years )
Introduction: IMBRUVICA is a medication containing ibrutinib, available in capsule, tablet, and suspension forms, indicated for various hematological conditions.
Health Affairs – Pharmaceutical Market Insights
WebMD – Blood Cancer Treatment Solutions
Domain: webmd.com
Registered: 1998 ( 27 years )
Introduction: Imbruvica (ibrutinib) is an oral medication used for the treatment of certain types of blood cancers.
Professionals – Imbruvica® for cGVHD Treatment
Domain: professionals.optumrx.com
Registered: 2011 ( 14 years )
Introduction: Imbruvica® (ibrutinib) is a medication approved for the treatment of adult and pediatric patients age 1 year and older with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.
Cda Amc – Targeted Blood Cancer Therapy
Domain: cda-amc.ca
Registered: 2024 ( 1 years )
Introduction: Ibrutinib is a targeted therapy used for the treatment of certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
Category Information
The keyword “Imbruvica manufacturer” pertains to the companies involved in the production and distribution of Imbruvica, a medication primarily used to treat various types of blood cancers, such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Imbruvica, known generically as ibrutinib, is a targeted therapy that inhibits Bruton’s tyrosine kinase, crucial for cancer cell proliferation and survival. The significance of identifying the manufacturer lies in understanding the drug’s quality, regulatory compliance, and availability.
Manufacturers play a critical role in ensuring that medications meet safety and efficacy standards set by health authorities. Additionally, knowledge about the manufacturer can influence healthcare decisions, pricing, and patient access to this vital treatment, highlighting the importance of transparency in pharmaceutical production and distribution.
Application Information
Imbruvica, manufactured by Pharmacyclics and Janssen Biotech, is primarily used in oncology and hematology, targeting specific blood cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). In the healthcare industry, it plays a crucial role in personalized medicine, allowing healthcare providers to tailor treatments based on individual patient needs and genetic profiles. Additionally, Imbruvica is utilized in research settings, contributing to studies on cancer biology and treatment efficacy.
Its role in clinical trials helps advance understanding of its effectiveness and safety, leading to potential new indications for other malignancies. Furthermore, in the pharmaceutical industry, Imbruvica is significant for its impact on drug development, shaping strategies around targeted therapies and combination treatments in oncology.
Production Process Information
Imbruvica, a medication used to treat certain types of cancer, goes through a detailed manufacturing process to ensure its safety and effectiveness. The typical production process involves several key stages. First, research and development are crucial. Scientists work to formulate the drug, conducting experiments to determine the right ingredients and dosages. Once the formulation is established, the drug must undergo rigorous testing to ensure it is safe for patients. This includes preclinical studies and clinical trials involving human participants.
After successful testing, the drug enters the manufacturing phase. Here, raw materials are sourced, and the drug is produced in large quantities under strict quality control standards. Finally, the product is packaged and distributed to pharmacies and hospitals, ensuring that patients have access to the medication. Throughout this process, compliance with regulatory requirements is essential to maintain safety and efficacy.
Related Video
Frequently Asked Questions (FAQs)
What should I look for when choosing an Imbruvica manufacturer?
When selecting an Imbruvica manufacturer, it’s essential to consider several factors. First, check for FDA approval and compliance with Good Manufacturing Practices (GMP). This ensures that the manufacturer adheres to high-quality standards. Additionally, look for a manufacturer with a solid track record in producing oncology drugs, as this can indicate experience and reliability. It’s also helpful to assess their production capacity and lead times to ensure they can meet your demands.
How can I verify the quality of an Imbruvica manufacturer?
To verify the quality of an Imbruvica manufacturer, start by requesting their certifications, such as GMP and ISO certifications. You can also look for third-party audits or reviews from other clients. If possible, visit the manufacturing facility to see the operations firsthand and ask about their quality control processes. Engaging with industry professionals or consulting organizations can also provide insights into the manufacturer’s reputation.
What are the costs associated with sourcing Imbruvica from manufacturers?
The costs of sourcing Imbruvica can vary widely depending on the manufacturer, production scale, and specific contract terms. Factors like minimum order quantities, shipping, and potential tariffs can also influence the overall cost. It’s a good idea to request quotes from multiple manufacturers and compare them, keeping in mind that the cheapest option may not always be the best in terms of quality and reliability.
How important is the location of the Imbruvica manufacturer?
The location of the manufacturer can play a significant role in logistics and cost efficiency. Choosing a manufacturer closer to your distribution center can reduce shipping times and costs. However, it’s also important to consider the manufacturer’s regulatory compliance and quality standards, which may be more crucial than location. Balancing these factors will help you make the best choice for your needs.
What should I ask potential Imbruvica manufacturers during the selection process?
When speaking with potential manufacturers, it’s vital to ask about their experience with Imbruvica and similar medications. Inquire about their production capabilities, quality control measures, and compliance with regulatory standards. You should also ask about their lead times, flexibility for order adjustments, and customer support. Understanding their communication practices and responsiveness can also give you insight into how well they will collaborate with you.